Methergin (Methylergometrine Maleate)

Methergin, an ergot alkaloid uterotonic, is used to manage conditions related to uterine muscle tone and bleeding.

• Postpartum hemorrhage: helps achieve rapid, sustained uterine contraction, thereby reducing ongoing blood loss and supporting hemostasis after vaginal or cesarean delivery.
• Uterine atony: restores muscular tone in a flaccid uterus, promoting effective compression of uterine vessels and facilitating control of bleeding when the uterus fails to contract spontaneously.
• Induction of labor: stimulates coordinated uterine contractions that advance cervical dilation, assisting clinicians in initiating or augmenting labor when medically indicated.

• Methylergometrine maleate acts as a partial agonist at serotonin 5‑HT2 receptors and alpha‑adrenergic receptors in uterine smooth muscle. Stimulation of these receptors increases intracellular calcium, enhancing muscle contractility and tone. The combined serotonergic and adrenergic activity produces sustained uterine contractions, which help compress uterine blood vessels and limit postpartum bleeding. The drug’s affinity for these receptors is higher in the pregnant uterus, providing a targeted effect with relatively limited systemic vasoconstriction.

Methylergometrine maleate may cause a range of adverse reactions, varying from mild, transient symptoms to potentially life‑threatening events.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset, often transient, may resolve without treatment.
• Vomiting: occasional emesis, usually self‑limiting within minutes, rarely requires intervention.
• Headache: dull or throbbing pain, may respond to simple analgesics, generally short‑lasting.
• Hypertension: modest rise in blood pressure, typically manageable with observation or medication.

Serious or Rare Side Effects

• Severe hypertension or hypertensive crisis: rapid, dangerous blood pressure elevation that may require urgent treatment to prevent organ damage.
• Myocardial ischemia or infarction: chest pain with possible cardiac injury, necessitating immediate medical attention and cardiac monitoring.
• Allergic reactions including anaphylaxis: hives, swelling, respiratory distress and circulatory collapse in extreme cases, requiring emergency care.

Key precautions should be observed when using methylergometrine maleate to minimize risks and ensure safe administration.

• Assess cardiovascular status: evaluate blood pressure and heart disease before use.
• Use lowest effective dose: limit exposure to reduce adverse events.
• Monitor for hypertension: check blood pressure regularly during and after administration.
• Observe for signs of uterine hyperstimulation: excessive contractions may compromise fetal oxygenation.
• Review concomitant vasoconstrictive drugs: avoid additive hypertensive effects.
• Avoid in patients with known hypersensitivity: discontinue if allergic reaction occurs.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methylergometrine maleate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• MAO inhibitors: risk of severe hypertension due to additive serotonergic activity.
• Ergot derivatives: cumulative vasoconstriction may cause ischemia.
• Sympathomimetic agents: heightened vascular tone leading to dangerous blood pressure spikes.
• Selective serotonin reuptake inhibitors (SSRIs): may increase serotonergic stimulation and precipitate hypertension.

Moderate Interactions (Monitor Closely)

• Antihypertensives: may blunt desired uterine contraction effect.
• Calcium channel blockers: could reduce drug‑induced uterine tone.
• NSAIDs: may mask early signs of hypertension.
• Beta‑blockers: may interfere with cardiovascular response, requiring monitoring.
• Anticoagulants: monitor for bleeding complications due to uterine activity.